Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials

Persistence of attention deficit hyperactivity disorder (ADHD) into adulthood can be disabling or lead to substantial impairment. Several clinical trials of atomoxetine (ATX) in adults with ADHD have been reported following the National Institute for Health and Clinical Excellence (NICE) guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales: Asherson, Philip, Bushe, Chris, Saylor, Keith, Tanaka, Yoko, Deberdt, Walter, Upadhyaya, Himanshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230847/
https://www.ncbi.nlm.nih.gov/pubmed/25035246
http://dx.doi.org/10.1177/0269881114542453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230847/
https://www.ncbi.nlm.nih.gov/pubmed/25035246
http://dx.doi.org/10.1177/0269881114542453

Ejemplares similares